Functional assays following CBX4 knockdown in colon cancer cells demonstrated that its silencing leads to a marked reduction in cell proliferation, induction of G2 cell cycle arrest, and impaired clonogenic potential, underscoring its contribution to tumor cell growth and survival. The gene discussed is CBX4; the disease is colonic neoplasm.